Xiaoxin X. Wang

3.4k total citations
39 papers, 2.1k citations indexed

About

Xiaoxin X. Wang is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Xiaoxin X. Wang has authored 39 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 11 papers in Oncology and 11 papers in Epidemiology. Recurrent topics in Xiaoxin X. Wang's work include Drug Transport and Resistance Mechanisms (10 papers), Liver Disease Diagnosis and Treatment (8 papers) and Cholesterol and Lipid Metabolism (7 papers). Xiaoxin X. Wang is often cited by papers focused on Drug Transport and Resistance Mechanisms (10 papers), Liver Disease Diagnosis and Treatment (8 papers) and Cholesterol and Lipid Metabolism (7 papers). Xiaoxin X. Wang collaborates with scholars based in United States, Israel and Japan. Xiaoxin X. Wang's co-authors include Moshe Levi, Tao Jiang, Luciano Adorini, Moshe Levi, Mark Pruzanski, Yuhuan Luo, Pnina Scherzer, Jeffrey B. Kopp, Evgenia Dobrinskikh and Yan Shen and has published in prestigious journals such as Journal of Biological Chemistry, Diabetes and The FASEB Journal.

In The Last Decade

Xiaoxin X. Wang

38 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaoxin X. Wang United States 22 657 550 528 483 480 39 2.1k
Jee‐Young Han South Korea 29 670 1.0× 341 0.6× 226 0.4× 570 1.2× 338 0.7× 56 2.1k
Miguel Arévalo Spain 24 909 1.4× 337 0.6× 271 0.5× 134 0.3× 135 0.3× 56 2.1k
Motohide Isono Japan 26 1.6k 2.4× 340 0.6× 269 0.5× 589 1.2× 295 0.6× 43 3.6k
Masahiko Igarashi Japan 23 1.2k 1.8× 462 0.8× 176 0.3× 682 1.4× 683 1.4× 56 3.2k
Hideaki Jinnouchi Japan 26 768 1.2× 550 1.0× 250 0.5× 1.1k 2.2× 259 0.5× 81 2.3k
Hirobumi Tokuyama Japan 26 880 1.3× 320 0.6× 143 0.3× 365 0.8× 422 0.9× 75 2.4k
Dongming Su China 21 911 1.4× 424 0.8× 122 0.2× 338 0.7× 375 0.8× 49 1.8k
Sung Kwang Park South Korea 24 935 1.4× 236 0.4× 288 0.5× 171 0.4× 231 0.5× 62 2.3k
Yuji Kamijo Japan 20 950 1.4× 226 0.4× 186 0.4× 130 0.3× 433 0.9× 99 1.8k
Silvia Pinach Italy 24 620 0.9× 389 0.7× 69 0.1× 549 1.1× 412 0.9× 44 1.9k

Countries citing papers authored by Xiaoxin X. Wang

Since Specialization
Citations

This map shows the geographic impact of Xiaoxin X. Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoxin X. Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoxin X. Wang more than expected).

Fields of papers citing papers by Xiaoxin X. Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoxin X. Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoxin X. Wang. The network helps show where Xiaoxin X. Wang may publish in the future.

Co-authorship network of co-authors of Xiaoxin X. Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoxin X. Wang. A scholar is included among the top collaborators of Xiaoxin X. Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoxin X. Wang. Xiaoxin X. Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Xiaoxin X., Kevin Barton, Komuraiah Myakala, et al.. (2025). Role of nuclear receptors, lipid metabolism, and mitochondrial function in the pathogenesis of diabetic kidney disease. American Journal of Physiology-Renal Physiology. 329(4). F510–F547. 3 indexed citations
2.
Myakala, Komuraiah, Xiaoxin X. Wang, Nataliia V. Shults, et al.. (2025). The nonsteroidal MR antagonist finerenone reverses Western diet-induced kidney disease by regulating mitochondrial and lipid metabolism and inflammation. American Journal of Physiology-Renal Physiology. 329(5). F724–F743.
3.
Yoshida, Teruhiko, Komuraiah Myakala, Bryce A. Jones, et al.. (2024). NAD deficiency contributes to progressive kidney disease in HIV-nephropathy mice. American Journal of Physiology-Renal Physiology. 327(3). F450–F462. 1 indexed citations
4.
Yoshida, Teruhiko, Avi Z. Rosenberg, Komuraiah Myakala, et al.. (2024). PKR activation-induced mitochondrial dysfunction in HIV-transgenic mice with nephropathy. eLife. 12. 1 indexed citations
5.
Li, Junyang, Feng Lü, Xiaoxin X. Wang, et al.. (2024). Amitriptyline revitalizes ICB response via dually inhibiting Kyn/Indole and 5-HT pathways of tryptophan metabolism in ovarian cancer. iScience. 27(12). 111488–111488. 2 indexed citations
6.
Jones, Bryce A., Komuraiah Myakala, Yue Yang, et al.. (2023). Farnesoid X receptor prevents neutrophil extracellular traps via reduced sphingosine-1-phosphate in chronic kidney disease. American Journal of Physiology-Renal Physiology. 325(6). F792–F810. 4 indexed citations
7.
Yoshida, Teruhiko, Avi Z. Rosenberg, Komuraiah Myakala, et al.. (2023). PKR activation-induced mitochondrial dysfunction in HIV-transgenic mice with nephropathy. eLife. 12. 3 indexed citations
8.
Zheng, Xiaoyi, Lauren E. Higdon, Alexandre Gaudet, et al.. (2022). Endothelial Cell-Specific Molecule-1 Inhibits Albuminuria in Diabetic Mice. Kidney360. 3(12). 2059–2076. 1 indexed citations
9.
Daneshpajouhnejad, Parnaz, Xiaoping Yang, Xiaoxin X. Wang, et al.. (2022). PodoCount: A Robust, Fully Automated, Whole-Slide Podocyte Quantification Tool. Kidney International Reports. 7(6). 1377–1392. 8 indexed citations
10.
Noothi, Sunil K., Sergio Li Calzi, Baskaran Athmanathan, et al.. (2020). Characterizing the Retinal Phenotype in the High-Fat Diet and Western Diet Mouse Models of Prediabetes. Cells. 9(2). 464–464. 34 indexed citations
11.
Chen, Jiayu, Qizhi Zheng, Lauren B. Peiffer, et al.. (2020). An in Situ Atlas of Mitochondrial DNA in Mammalian Tissues Reveals High Content in Stem and Proliferative Compartments. American Journal Of Pathology. 190(7). 1565–1579. 19 indexed citations
12.
Takahashi, Shogo, Yuhuan Luo, Suman Ranjit, et al.. (2020). Bile acid sequestration reverses liver injury and prevents progression of nonalcoholic steatohepatitis in Western diet–fed mice. Journal of Biological Chemistry. 295(14). 4733–4747. 50 indexed citations
13.
Wang, Xiaoxin X., Yuhuan Luo, Dong Wang, et al.. (2017). A dual agonist of farnesoid X receptor (FXR) and the G protein–coupled receptor TGR5, INT-767, reverses age-related kidney disease in mice. Journal of Biological Chemistry. 292(29). 12018–12024. 52 indexed citations
14.
McMahan, Rachel H., Yuhuan Luo, Xiaoxin X. Wang, et al.. (2016). Sevelamer Improves Steatohepatitis, Inhibits Liver and Intestinal Farnesoid X Receptor (FXR), and Reverses Innate Immune Dysregulation in a Mouse Model of Non-alcoholic Fatty Liver Disease. Journal of Biological Chemistry. 291(44). 23058–23067. 29 indexed citations
15.
McMahan, Rachel H., Xiaoxin X. Wang, Lin Cheng, et al.. (2013). Bile Acid Receptor Activation Modulates Hepatic Monocyte Activity and Improves Nonalcoholic Fatty Liver Disease. Journal of Biological Chemistry. 288(17). 11761–11770. 189 indexed citations
16.
Patel, Monika, Xiaoxin X. Wang, Lilia Magomedova, et al.. (2013). Liver X receptors preserve renal glomerular integrity under normoglycaemia and in diabetes in mice. Diabetologia. 57(2). 435–446. 35 indexed citations
17.
Tak, Eunyoung, Douglas Ridyard, Jaehwan Kim, et al.. (2013). CD73-Dependent Generation of Adenosine and Endothelial Adora2b Signaling Attenuate Diabetic Nephropathy. Journal of the American Society of Nephrology. 25(3). 547–563. 43 indexed citations
18.
Wang, Xiaoxin X., et al.. (2011). Vitamin D receptor agonist doxercalciferol modulates dietary fat-induced renal disease and renal lipid metabolism. American Journal of Physiology-Renal Physiology. 300(3). F801–F810. 69 indexed citations
19.
Rizzo, Giovanni, Daniela Passeri, Francesca Franco, et al.. (2010). Functional Characterization Of The Semi-Synthetic Bile Acid Derivative Int-767, A Dual Fxr And Tgr5 Agonist. Journal of Hepatology. 52. 430–431. 1 indexed citations
20.
Rizzo, Giovanni, Daniela Passeri, Francesca Franco, et al.. (2010). Functional Characterization of the Semisynthetic Bile Acid Derivative INT-767, a Dual Farnesoid X Receptor and TGR5 Agonist. Molecular Pharmacology. 78(4). 617–630. 156 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jee‐Young Han Breakdown of academic impact, for papers by Miguel Arévalo Breakdown of academic impact, for papers by Motohide Isono Breakdown of academic impact, for papers by Masahiko Igarashi Breakdown of academic impact, for papers by Hideaki Jinnouchi Breakdown of academic impact, for papers by Hirobumi Tokuyama Breakdown of academic impact, for papers by Dongming Su Breakdown of academic impact, for papers by Sung Kwang Park Breakdown of academic impact, for papers by Yuji Kamijo Breakdown of academic impact, for papers by Silvia Pinach
Rankless by CCL
2026